Lista de obras - Katia Mazzocco - Dominio Público Uruguay

A multilocus technique for risk evaluation of patients with neuroblastoma

artículo científico publicado en 2011

Biological and clinical role of p73 in neuroblastoma

artículo científico publicado en 2003

Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins

artículo científico publicado en 2012

Concomitant DDX1 and MYCN gain in neuroblastoma

artículo científico publicado en 2007

Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.

artículo científico publicado en 2013

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

artículo científico publicado en 2017

Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization

artículo científico publicado en 2004

Evidence of apoptosis in neuroblastoma at onset and relapse. An analysis of a large series of tumors

scientific article published on 01 January 1997

Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients

artículo científico publicado en 2002

Gene expression and protein localisation of calcyclin, a calcium-binding protein of the S-100 family in fresh neuroblastomas

artículo científico publicado en 1995

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group

artículo científico publicado en 2015

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

artículo científico publicado en 2005

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

artículo científico publicado en 2018

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study

artículo científico publicado en 2018

Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma

scientific article published on 01 May 2003

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization

artículo científico publicado en 2007

Identification of an AP-1-like sequence in the promoter region of calcyclin, a S-100-like gene. Enhancement of binding during retinoic acid-induced neuroblastoma cell differentiation.

artículo científico publicado en 1994

Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma

scientific article published on 01 October 2008

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

artículo científico publicado en 2014

Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome

artículo científico publicado en 1998

Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.

artículo científico publicado en 2002

Loss of heterozygosity for chromosome 1p in familial neuroblastoma

scientific article published on 01 October 1997

MDM2SNP309 genotype influences survival of metastatic but not of localized neuroblastoma

artículo científico publicado en 2009

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children

scientific article published on 01 January 1997

Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases

artículo científico publicado en 2003

Neuroblastoma in adolescents

artículo científico publicado en 2006

Neuroblastoma in the adult: the Italian experience with 21 patients

scientific article published on 01 November 2014

Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development

scientific article published on 01 March 1999

Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients

artículo científico publicado en 2010

Peculiar allelotype associated with susceptibility to neuroblastoma

artículo científico publicado en 1996

Piloting the European Unified Patient Identity Management (EUPID) Concept to Facilitate Secondary Use of Neuroblastoma Data from Clinical Trials and Biobanking.

artículo científico publicado en 2016

Quality assessment of genetic markers used for therapy stratification.

artículo científico publicado en 2003

Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system

artículo científico publicado en 1999

Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients

artículo científico publicado en 1997

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

artículo científico publicado en 2011

Simultaneous tumors: acute myeloid leukemia infiltrating mediastinal ganglioneuroblastoma

scientific article published on 01 February 2011

Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease

artículo científico publicado en 2018

Stage-independent expression and genetic analysis of tp73 in neuroblastoma.

artículo científico publicado en 1999

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis

artículo científico publicado en 2009

Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors

scientific article published on 01 May 2002

[Oncogenes and suppressor genes in the genesis and progression of solid tumors in children]

artículo científico publicado en 1994

[The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)]

scientific article published on 01 May 1994

Lista de obras de Katia Mazzocco

A multilocus technique for risk evaluation of patients with neuroblastoma

Biological and clinical role of p73 in neuroblastoma

Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins

Concomitant DDX1 and MYCN gain in neuroblastoma

Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization

Evidence of apoptosis in neuroblastoma at onset and relapse. An analysis of a large series of tumors

Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients

Gene expression and protein localisation of calcyclin, a calcium-binding protein of the S-100 family in fresh neuroblastomas

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study

Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization

Identification of an AP-1-like sequence in the promoter region of calcyclin, a S-100-like gene. Enhancement of binding during retinoic acid-induced neuroblastoma cell differentiation.

Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome

Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.

Loss of heterozygosity for chromosome 1p in familial neuroblastoma

MDM2SNP309 genotype influences survival of metastatic but not of localized neuroblastoma

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children

Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases

Neuroblastoma in adolescents

Neuroblastoma in the adult: the Italian experience with 21 patients

Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development

Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients

Peculiar allelotype associated with susceptibility to neuroblastoma

Piloting the European Unified Patient Identity Management (EUPID) Concept to Facilitate Secondary Use of Neuroblastoma Data from Clinical Trials and Biobanking.

Quality assessment of genetic markers used for therapy stratification.

Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system

Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Simultaneous tumors: acute myeloid leukemia infiltrating mediastinal ganglioneuroblastoma

Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease

Stage-independent expression and genetic analysis of tp73 in neuroblastoma.

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis

Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors

[Oncogenes and suppressor genes in the genesis and progression of solid tumors in children]

[The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)]